Hang JW et al., 2025-11-26: Non-human primate study in Plasmodium coatneyi-infected rhesus macaques reporting that methylene blue reverses infection-driven brainstem gene-expression changes and nominating nine blood biomarker genes for fatal cerebral malaria.
Through differential gene expression analysis, our study demonstrates methylene blue's efficacy in reversing the detrimental effects of infection on the brainstem.
Abstract
Hang JW et al., 2025-11-26: Non-human primate study in Plasmodium coatneyi-infected rhesus macaques reporting that methylene blue reverses infection-driven brainstem gene-expression changes and nominating nine blood biomarker genes for fatal cerebral malaria. Study type: animal study (non-human primate, Macaca mulatta infected with Plasmodium coatneyi); not a human trial. Country: Singapore/Thailand/US collaboration (A*STAR SIgN, Mahidol, NIH). MB dose/route not stated in the abstract. Comparator: infected untreated animals. Funding: NIAID U19 AI089676, Singapore Ministry of Education MOE2019-T3-1-007, A*STAR SINGA. Competing interests: none declared. Supports mechanistic rationale in severe malaria; not human efficacy evidence. Study type: animal.
